A detailed history of Redmile Group, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,660,763 shares of ARDX stock, worth $8.64 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
1,660,763
Previous 1,881,501 11.73%
Holding current value
$8.64 Million
Previous $13.9 Million 17.93%
% of portfolio
0.75%
Previous 0.91%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.28 - $7.57 $1.17 Million - $1.67 Million
-220,738 Reduced 11.73%
1,660,763 $11.4 Million
Q2 2024

Aug 14, 2024

SELL
$5.89 - $9.31 $1.84 Million - $2.91 Million
-313,059 Reduced 14.27%
1,881,501 $13.9 Million
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $13.3 Million - $21.4 Million
2,194,560 New
2,194,560 $16 Million
Q3 2021

Nov 15, 2021

SELL
$1.27 - $8.17 $4.72 Million - $30.3 Million
-3,714,100 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.55 - $8.98 $1.31 Million - $1.8 Million
200,000 Added 5.69%
3,714,100 $28.2 Million
Q2 2020

Aug 14, 2020

SELL
$5.37 - $8.11 $2.09 Million - $3.16 Million
-390,000 Reduced 9.99%
3,514,100 $24.3 Million
Q1 2020

May 15, 2020

SELL
$4.35 - $8.79 $417,164 - $842,960
-95,900 Reduced 2.4%
3,904,100 $22.2 Million
Q4 2019

Feb 14, 2020

BUY
$4.23 - $8.29 $16.9 Million - $33.2 Million
4,000,000 New
4,000,000 $30 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $804M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.